How severe is CVE-2021-41325?

CVE-2021-41325 has a CVSS 3.x base score of 6.5, rated medium severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is none, integrity high, and availability none.

Is CVE-2021-41325 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (62nd percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2021-41325?

CVE-2021-41325 primarily affects Pydio Cells. In total, 2 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.

How do I fix CVE-2021-41325?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.

When was CVE-2021-41325 published?

CVE-2021-41325 was published on 2021-09-30 and last updated on 2026-06-17.

CVE-2021-41325

CVE-2021-41325 is a medium-severity vulnerability in Pydio Cells with a CVSS 3.x base score of 6.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low.

Key facts

Severity: Medium (CVSS 3.x base score 6.5)
CVSS v2: 4.0
EPSS exploit prediction: 1% (62nd percentile)
Actively exploited: Not listed in CISA KEV
Affected product: Pydio Cells
Published: 2021-09-30
Last modified: 2026-06-17

Description

Broken access control for user creation in Pydio Cells 2.2.9 allows remote anonymous users to create standard users via the profile parameter. (In addition, such users can be granted several admin permissions via the Roles parameter.)

Frequently asked questions

What is CVE-2021-41325?: Broken access control for user creation in Pydio Cells 2.2.9 allows remote anonymous users to create standard users via the profile parameter. (In addition, such users can be granted several admin permissions via the Roles parameter.)
How severe is CVE-2021-41325?: CVE-2021-41325 has a CVSS 3.x base score of 6.5, rated medium severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is none, integrity high, and availability none.
Is CVE-2021-41325 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (62nd percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2021-41325?: CVE-2021-41325 primarily affects Pydio Cells. In total, 2 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2021-41325?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2021-41325 published?: CVE-2021-41325 was published on 2021-09-30 and last updated on 2026-06-17.

References

Affected products (2)

cpe:2.3:a:pydio:cells:2.2.9:*:*:*:-:*:*:*
cpe:2.3:a:pydio:cells:2.2.9:*:*:*:enterprise:*:*:*

More vulnerabilities in Pydio Cells

CVE-2023-32749 — High (CVSS 8.8): Pydio Cells allows users by default to create so-called external users in order to share files with them. By modifying…
CVE-2019-12901 — High (CVSS 8.8): Pydio Cells before 1.5.0 fails to neutralize '../' elements, allowing an attacker with minimum privilege to Upload…
CVE-2020-12851 — High (CVSS 8.1): Pydio Cells 2.0.4 allows an authenticated user to write or overwrite existing files in another user’s personal and…
CVE-2020-12847 — High (CVSS 7.2): Pydio Cells 2.0.4 web application offers an administrative console named “Cells Console” that is available to users…
CVE-2020-12850 — High (CVSS 7.0): The following vulnerability applies only to the Pydio Cells Enterprise OVF version 2.0.4. Prior versions of the Pydio…
CVE-2020-12852 — Medium (CVSS 6.8): The update feature for Pydio Cells 2.0.4 allows an administrator user to set a custom update URL and the public RSA key…

All CVEs affecting Pydio Cells →